CYP2C192 Polymorphism in Chilean Patients with In-Stent Restenosis Development and Controls

Table 1

Clinical and demographic characteristics of the study group.

Parameter	Patients with restenosis	Controls	value
	Age (years)	62.75 ± 9.8		65.45 ± 9.8	0.08
Male (%)	80.5	72.1	0.20
BMI (kg/m^2)	27.6 ± 3.8	28.0 ± 3.35	0.39
SBP (mmHg)	131.4 ± 22.2	135.0 ± 26	0.36
DBP (mmHg)	72.58 ± 14.0	72.47 ± 14.3	0.97
Heart rate (bpm)	69.4 ± 14.5	69.1 ± 14.3	0.37
Glucose (mg/dL)	135.3 ± 63.6	117.0 ± 42.5	0.14
Diabetes mellitus (%)	42	27	0.05
Dyslipidemia (%)	81	75	0.38
Total cholesterol (mg/dL)	159.0 ± 49.0	181.9 ± 128.0	0.26
Triglycerides (mg/dL)	160.4 ± 145.4	159.9 ± 85.8	0.12
LDL-C (mg/dL)	96.38 ± 54.0	99.40 ± 38.5	0.34
HDL-C (mg/dL)	40.78 ± 16.1	36.62 ± 7.9	0.48
Smoking (%)	77.8	69.0	0.29
Myocardial infarction (%)	45.6	32.9	0.12
Creatinine (mg/dL)	0.98 ± 0.28	1.02 ± 0.68	0.52
HbA1c (%)	6.58 ± 1.9	6.40 ± 1.25	0.23

Values expressed as mean ± standard deviation. SBP: systolic blood pressure; DBP: diastolic blood pressure; HDL-C: high-density lipoprotein-cholesterol; LDL-C: low-density lipoprotein-cholesterol; TG: triglycerides; HbA1c: glycosylated hemoglobin; HR: heart rate.